SCHEMBL6891974

SCHEMBL6891974

CCCCCCCC/C=C\CCCCCCCC(=O)NO

nearest known ligand 0.90

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 1/20 0.77
TERT O14746 3/20 0.63
PTPN1 P18031 3/20 0.63
PPARG P37231 3/20 0.63
PPARD Q03181 3/20 0.63
PPARA Q07869 3/20 0.63
CYP1A2 P05177 2/20 0.63
MAPT P10636 2/20 0.63
CYP2C19 P33261 2/20 0.63
BLM P54132 2/20 0.63
HSD17B10 Q99714 2/20 0.63
FABP4 P15090 2/20 0.63
FAAH O00519 2/20 0.63
KMT2A Q03164 2/20 0.63
GMNN O75496 1/20 0.63
USP2 O75604 1/20 0.63
LMNA P02545 1/20 0.63
POLB P06746 1/20 0.63
CYP2C9 P11712 1/20 0.63
ALOX15 P16050 1/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25712483 1.00 HSP90AA1 (0.77) HSP90AA1TERTPTPN1PPARGPPARD
SCHEMBL15061596 1.00 HSP90AA1 (0.77) HSP90AA1TERTPTPN1PPARGPPARD
SCHEMBL2680708 1.00 HSP90AA1 (0.77) HSP90AA1TERTPTPN1PPARGPPARD
SCHEMBL13400832 1.00 HSP90AA1 (0.77) HSP90AA1TERTPTPN1PPARGPPARD
SCHEMBL3492921 1.00 HSP90AA1 (0.77) HSP90AA1TERTPTPN1PPARGPPARD
SCHEMBL22190346 1.00 HSP90AA1 (0.77) HSP90AA1TERTPTPN1PPARGPPARD
Potassium SCHEMBL32681948 0.98 HSP90AA1 (0.74) HSP90AA1TERTPTPN1PPARGPPARD
SCHEMBL1928628 0.95 MEN1 (0.69) HSP90AA1PPARGPPARDPPARAMAPT
SCHEMBL3154754 0.89 CNR1 (0.71) PPARGPPARDPPARAMAPTBLM
SCHEMBL9319819 0.89 HSP90AA1 (0.59) HSP90AA1PPARGPPARDPPARAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-59146423-A None JP disclosed
US-12569861-B2 Compounds, methods, and systems for benefication of rare earth elements by flotation and gravity concentration COLORADO SCHOOL OF MINES (US) 2026-03-10 US disclosed
EP-4701410-A1 STRIP FOR RELEASING AN ANTIPARASITIC COMPOSITION TO BEES TO CONTROL PARASITIC INFECTIONS IN BEEHIVES Laboratorios Calier, S.A. (ES) 2026-03-04 EP disclosed
EP-4701409-A1 ANTIPARASITIC COMPOSITION TO CONTROL PARASITIC INFECTIONS IN BEEHIVES Laboratorios Calier, S.A. (ES) 2026-03-04 EP disclosed
EP-3651785-B1 COMPOSITIONS AND METHODS FOR TREATING MYELIN DISORDERS UNIV CASE WESTERN RESERVE (US) 2025-11-12 EP disclosed
WO-2024223764-A1 STRIP FOR RELEASING AN ANTIPARASITIC COMPOSITION TO BEES TO CONTROL PARASITIC INFECTIONS IN BEEHIVES. LABORATORIOS CALIER, S. A. (ES) 2024-10-31 WO disclosed
WO-2024223754-A1 ANTIPARASITIC COMPOSITION TO CONTROL PARASITIC INFECTIONS IN BEEHIVES LABORATORIOS CALIER, S. A. (ES) 2024-10-31 WO disclosed
WO-2023056350-A9 BIOSYNTHESIS OF CANNABINOIDS AND CANNABINOID PRECURSORS GINKGO BIOWORKS, INC. (US) 2024-04-11 WO disclosed
CN-114907514-A Multifunctional fiber and preparation method and application thereof 北京洁尔爽高科技有限公司 2022-08-16 CN disclosed
CN-112236507-A Selective hydration of oleic acid derivatives 帝斯曼知识产权资产管理有限公司 2021-01-15 CN disclosed
EP-0639240-B1 MICROENCAPSULATED OIL FIELD CHEMICALS AND PROCESS FOR THEIR USE PROCTER & GAMBLE (US) 1997-02-26 EP disclosed
EP-0639240-A1 MICROENCAPSULATED OIL FIELD CHEMICALS AND PROCESS FOR THEIR USE. PROCTER & GAMBLE (US) 1995-02-22 EP disclosed
WO-1993022537-A1 MICROENCAPSULATED OIL FIELD CHEMICALS AND PROCESS FOR THEIR USE THE PROCTER & GAMBLE COMPANY (US) 1993-11-11 WO disclosed
US-4857149-A SIZING COMPOUND CONTAINING BOTH HYDROPHILIC AND HYDROPHOBIC PO RTIONS; ALKOYL OR ALKENOYL HYDROZAMIC ACID WEYERHAEUSER COMPANY (US) 1989-08-15 US disclosed
WO-1988002047-A1 METHOD AND PRODUCTS FOR SIZING PAPER AND SIMILAR MATERIALS WEYERHAEUSER COMPANY (US) 1988-03-24 WO disclosed
US-4629556-A REMOVAL OF COLORED IMPURITIES; PAPERMAKING THIELE KAOLIN COMPANY (US) 1986-12-16 US disclosed
JP-S59146423-A MAGNETIC HEAD CANON ELECTRONICS INC 1984-08-22 JP disclosed
US-4450116-A FLOTATION AGENTS FOR TIN-CONTAINING ORES HOECHST AKTIENGESELLSCHAFT (DE) 1984-05-22 US disclosed
EP-0070534-A1 3-Alkoxypropylene-imino-bis(methylenephosphonic acids) and their salts, process for their preparation and their use HOECHST AKTIENGESELLSCHAFT (DE) 1983-01-26 EP disclosed
US-4198931-A ANTI-WEAR COMPRESSION IGNITION FUEL COMPRISING ALCOHOL AND N-HYDROXY HYDROCARBONAMIDE ETHYL CORPORATION (US) 1980-04-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12569861-B2 Compounds, methods, and systems for benefication of rare earth elements by flotation and gravity concentration SART3, RPL30, CASR HSP90AA1 4672/4885TERT 2316/4885PTPN1 2795/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.